BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 20394284)

  • 1. [Study on density quality control of crude pyritum].
    Wang H; Xiao J; Cai H; Cai B
    Zhongguo Zhong Yao Za Zhi; 2010 Jan; 35(2):162-5. PubMed ID: 20394284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [FeS2 changes in ignited pyritum].
    Li TL; Jiang WJ; Li C; Ma YL; Yang J
    Zhongguo Zhong Yao Za Zhi; 1993 Nov; 18(11):662-4, 702. PubMed ID: 8003226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Processing of pyritum from different sources].
    Li X; Zhang S; Liu Z; Wang Z; Xia J; Zhang F
    Zhongguo Zhong Yao Za Zhi; 1995 Aug; 20(8):467-9, 511. PubMed ID: 8561882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Research on X-ray diffraction fingerprints of crude and processed pyritum].
    Lei Y; Li W; Li J; Cai B
    Zhongguo Zhong Yao Za Zhi; 2010 Oct; 35(19):2561-4. PubMed ID: 21174765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Quality control of traditional Tibetan Medicine Zsuotai].
    Xia ZJ; Wei LX; Wang DP; Du YZ; Chen XM; Yang HX
    Zhong Yao Cai; 2010 May; 33(5):688-90. PubMed ID: 20873550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the traditional aspect of Chinese medicine in order to achieve meaningful quality control of Chinese materia medica.
    Xie PS; Leung AY
    J Chromatogr A; 2009 Mar; 1216(11):1933-40. PubMed ID: 18757061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Various methods of processing pyritum].
    Li X; Shi C; Cui X
    Zhongguo Zhong Yao Za Zhi; 1991 Oct; 16(10):598-600, 639-40. PubMed ID: 1820791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advance in quality assessment of Chinese materia medica using microscopic and morphological methods.
    Miao XS; Cui QY; Wang ZY; Liu XN; Zhao AB; Qiao YJ; Wu ZS
    Chin J Nat Med; 2017 Sep; 15(9):653-663. PubMed ID: 28991526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison Study of Bone Defect Healing Effect of Raw and Processed Pyritum in Rats.
    Zhu X; Gao Q; Zhao G; Wang H; Liu L; Chen Z; Chen Y; Wu L; Xu Z; Li W
    Biol Trace Elem Res; 2018 Jul; 184(1):136-147. PubMed ID: 28980123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Substance basis research on Chinese materia medica is one of key scientific problems of inheriting, development and innovation of Chinese materia medica].
    Yang XW
    Zhongguo Zhong Yao Za Zhi; 2015 Sep; 40(17):3429-34. PubMed ID: 26978985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Microscopic quantitative study on Saiga tatarica in "lingyang qing fei pill"].
    Jiang Q; Zhai Y; Wang R
    Zhong Yao Cai; 2004 Feb; 27(2):90-1. PubMed ID: 22454994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mining and Correlation Analysis of Association Rules between Properties and Therapeutic Efficacy of Chinese Materia Medica Based on Strategy Pattern.
    Wu DY; Zhang XY; Zhou XL
    Chin Med J (Engl); 2018 Nov; 131(22):2755-2757. PubMed ID: 30425205
    [No Abstract]   [Full Text] [Related]  

  • 13. Authentication of the 31 species of toxic and potent Chinese Materia medica (T/PCMM) by microscopic technique, part 1: three kinds of toxic and potent animal CMM.
    Xia L; Bai LP; Yi L; Liu BB; Chu C; Liang ZT; Li P; Jiang ZH; Zhao ZZ
    Microsc Res Tech; 2007 Nov; 70(11):960-8. PubMed ID: 17661389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Construction of biopharmaceutics classification system of Chinese materia medica].
    Liu Y; Wei L; Dong L; Zhu ML; Tang MM; Zhang L
    Zhongguo Zhong Yao Za Zhi; 2014 Dec; 39(23):4479-83. PubMed ID: 25911786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of mid-infrared spectroscopy in the quality control of traditional Chinese medicines.
    Sun S; Chen J; Zhou Q; Lu G; Chan K
    Planta Med; 2010 Dec; 76(17):1987-96. PubMed ID: 21049394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Investigation of multi-composition in traditional Chinese medicine by module calculation].
    Li Z; Wang X; Wu GQ; Zhang XQ; Fang Y
    Zhongguo Zhong Yao Za Zhi; 2008 Sep; 33(17):2097-9. PubMed ID: 19066049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PAT: From Western solid dosage forms to Chinese materia medica preparations using NIR-CI.
    Zhou L; Xu M; Wu Z; Shi X; Qiao Y
    Drug Test Anal; 2016 Jan; 8(1):71-85. PubMed ID: 25877484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on the quality standard of xingnao tinctures].
    Huang RS
    Zhongguo Zhong Yao Za Zhi; 2003 Aug; 28(8):724-7. PubMed ID: 15015351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Status and future of natural resource for Chinese materia medica].
    Ma XJ; Guo J; Tang JF; Ma XH; Ma Y; Dai ZB; Guo LP; Huang LQ
    Zhongguo Zhong Yao Za Zhi; 2015 May; 40(10):1887-92. PubMed ID: 26390642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on differences between pharmacokinetics and chromatopharmacodynamics for Chinese materia medica formulae].
    He F; Deng K; Zou H; Qiu Y; Chen F; Zhou H
    Zhongguo Zhong Yao Za Zhi; 2011 Jan; 36(2):136-41. PubMed ID: 21506409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.